Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.385 AUD | -1.07% | +9.49% | +17.37% |
Apr. 16 | XRF Scientific's Profit Before Tax Rises 15% in March Quarter | MT |
Feb. 20 | XRF Scientific Shares Decline 5% Despite Higher Fiscal H1 Revenue, EPS | MT |
Business Summary
Number of employees: 48
Sales per Business
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Precious Metals
37.5
%
| 18 | 44.2 % | 21 | 37.5 % | +16.94% |
Capital Equipment
31.8
%
| 10 | 25.5 % | 18 | 31.8 % | +71.87% |
Consumables
30.7
%
| 12 | 30.3 % | 17 | 30.7 % | +39.94% |
Sales per region
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Australia
67.6
%
| 26 | 63.9 % | 37 | 67.6 % | +45.88% |
Europe
23.2
%
| 10 | 25.6 % | 13 | 23.2 % | +25.11% |
Canada
9.2
%
| 4 | 10.5 % | 5 | 9.2 % | +20.57% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 08-05-31 | |
Andrew Watson
DFI | Director of Finance/CFO | - | 13-08-27 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Fred Grimwade
CHM | Chairman | 66 | 12-04-30 |
David Kiggins
BRD | Director/Board Member | 54 | 12-04-30 |
David Brown
BRD | Director/Board Member | 86 | 04-06-06 |
Chief Executive Officer | - | 08-05-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 138,041,277 | 87,913,517 ( 63.69 %) | 0 | 63.69 % |
Company contact information
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.64% | 126M | |
+25.25% | 5.19B | |
+23.95% | 4.5B | |
+24.10% | 1.62B | |
-15.97% | 1.09B | |
+8.01% | 1.07B | |
-38.02% | 875M | |
+19.32% | 748M | |
+1.09% | 445M | |
-16.27% | 326M |
- Stock Market
- Equities
- XRF Stock
- Company XRF Scientific Limited